StocksJ › JPM

JPMorgan Chase & Co. (JPM) — Earnings Call X-Ray

Our AI read all 40 of JPM's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q2 2025 · sign up to see
Previous Call Grade
D
Q1 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
40
2016–2025
Avg Candor
7.6/9
evasion 2.9/9
High CandorSkeptic ReassuredCritic AmmunitionCapex IncreasingCFO DominatesQuestion Left Hanging

Call-by-call analysis

🔒 Q2 2025 earnings call 2025-07-15 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q2 2025 call grade is ready
The full 37-point AI read of JPM's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

D Q1 2025 earnings call 2025-04-11 move ±10.3%

Management held guidance steady against mixed demand signals. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: mixedMargins: stableBacklog: shrinkingHeadcount: growingCapex: increasing 11 analysts · 18 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hangingCFO dominates
Candor 8/9
Specificity 7/9
Evasion 5/9
Confidence 6/9
Uncertainty 8/9
Promotion 3/9
Stress 4/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?

C+ Q4 2024 earnings call 2025-01-15 move ±7.2%

Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: contractingPricing: stableHeadcount: flatCapex: increasing 7 analysts · 11 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubtsCFO dominates
Candor 7/9
Specificity 8/9
Evasion 4/9
Confidence 8/9
Uncertainty 5/9
Promotion 3/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q3 2024 earnings call 2024-10-11 move ±6.9%

Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: contractingBacklog: growingPricing: under pressureHeadcount: growingCapex: increasing 10 analysts · 18 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsCFO dominates
Candor 7/9
Specificity 8/9
Evasion 4/9
Confidence 7/9
Uncertainty 5/9
Promotion 3/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q2 2024 earnings call 2024-07-12 move ±8.3%

Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: mixedMargins: contractingBacklog: growingPricing: under pressureHeadcount: growing 10 analysts · 18 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsCFO dominates
Candor 8/9
Specificity 9/9
Evasion 3/9
Confidence 7/9
Uncertainty 6/9
Promotion 3/9
Stress 2/9
Complexity 7/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q1 2024 earnings call 2024-04-12 move ±7.2%

Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: contractingPricing: stableHeadcount: growingCapex: increasing 11 analysts · 22 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsCFO dominates
Candor 8/9
Specificity 9/9
Evasion 3/9
Confidence 7/9
Uncertainty 7/9
Promotion 3/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q4 2023 earnings call 2024-01-12 move ±6.1%

Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: mixedMargins: contractingPricing: stableHeadcount: growingCapex: increasing 10 analysts · 19 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsCFO dominates
Candor 8/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 6/9
Promotion 4/9
Stress 2/9
Complexity 7/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q3 2023 earnings call 2023-10-13 move ±5.9%

Management raised guidance against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: stableMargins: expandingPricing: raisingHeadcount: growingCapex: increasing 10 analysts · 20 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubtsCFO dominates
Candor 8/9
Specificity 9/9
Evasion 3/9
Confidence 7/9
Uncertainty 7/9
Promotion 3/9
Stress 4/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q2 2023 2023-07-14 B+ raisedmixedexpanding 8/9 2/9
Q1 2023 2023-04-14 B raisedstableexpanding 7/9 3/9
Q4 2022 2023-01-13 C+ maintainedmixedcontracting 7/9 4/9
Q3 2022 2022-10-14 B+ raisedstableexpanding 8/9 2/9
Q2 2022 2022-07-14 B raisedstableunclear 8/9 2/9
Q1 2022 2022-04-13 C maintainedacceleratingcontracting 7/9 5/9
Q4 2021 2022-01-14 C+ maintainedstablecontracting 7/9 4/9
Q3 2021 2021-10-13 B+ maintainedmixedstable 7/9 4/9
Q2 2021 2021-07-13 A raisedacceleratingcontracting 8/9 2/9
Q1 2021 2021-05-06 D maintainedacceleratingunclear 6/9 4/9
Q1 2021 2021-04-14 B+ raisedmixedstable 8/9 2/9
Q4 2020 2021-01-15 B+ raisedmixedcontracting 8/9 4/9
Q3 2020 2020-10-14 C+ maintainedmixedcontracting 7/9 4/9
Q2 2020 2020-07-14 B maintainedmixedcontracting 8/9 3/9
Q1 2020 2020-04-14 C loweredmixedcontracting 8/9 4/9
Q4 2019 2020-01-14 B maintainedstablestable 7/9 2/9
Q3 2019 2019-10-15 C+ maintainedstablecontracting 7/9 4/9
Q2 2019 2019-07-16 B+ loweredstableexpanding 8/9 2/9
Q1 2019 2019-04-12 A maintainedstableexpanding 8/9 2/9
Q4 2018 2019-01-15 A maintainedstablestable 8/9 2/9
Q3 2018 2018-10-12 B+ maintainedstableexpanding 8/9 2/9
Q2 2018 2018-07-13 B maintainedstableexpanding 8/9 2/9
Q1 2018 2018-04-13 C+ maintainedstableexpanding 7/9 3/9
Q4 2017 2018-01-12 B+ maintainedacceleratingexpanding 8/9 3/9
Q3 2017 2017-10-12 A maintainedstableexpanding 8/9 2/9
Q2 2017 2017-07-14 B loweredstablestable 8/9 1/9
Q1 2017 2017-04-13 B+ raisedstableexpanding 8/9 2/9
Q4 2016 2017-01-13 A maintainedacceleratingexpanding 8/9 2/9
Q3 2016 2016-10-14 A maintainedacceleratingexpanding 8/9 2/9
Q2 2016 2016-07-14 B raisedacceleratingstable 7/9 4/9
Q1 2016 2016-04-13 B+ maintainedmixedstable 8/9 2/9
Q4 2015 2016-01-14 B+ maintainedstablestable 8/9 2/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of JPM's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

C+ Q4 2022 earnings call 2023-01-13

1 more research questions answered NO

A Q2 2021 earnings call 2021-07-13

289 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAC · AAC Holdings'AACAY · AAC Technologies HoldingAACG · ATA Creativity GlobalAADI · Aadi Bioscience, Inc.AALBF · Aalberts N.V.AAOI · Applied Optoelectronics,

JPEP   All “J” companies    JPPYY

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.